000 | 01031 a2200277 4500 | ||
---|---|---|---|
005 | 20250518021437.0 | ||
264 | 0 | _c20200513 | |
008 | 202005s 0 0 eng d | ||
022 | _a1531-7048 | ||
024 | 7 |
_a10.1097/MOH.0000000000000486 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFletcher, Luke | |
245 | 0 | 0 |
_aNovel Approaches for Systemic Mastocytosis. _h[electronic resource] |
260 |
_bCurrent opinion in hematology _c03 2019 |
||
300 |
_a112-118 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMastocytosis, Systemic _xdrug therapy |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 | _aProto-Oncogene Mas |
650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors |
700 | 1 | _aBorate, Uma | |
773 | 0 |
_tCurrent opinion in hematology _gvol. 26 _gno. 2 _gp. 112-118 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/MOH.0000000000000486 _zAvailable from publisher's website |
999 |
_c29304989 _d29304989 |